Rankings Pricing

SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】Income statement

Market cap

¥573.5B

P/E ratio

16.3x

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Revenue	114,416	119,066	148,663	161,881	195,291	199,096	224,942	234,026	241,555	249,605	266,257	279,037	301,965	300,004
Cost of revenue	-	-	-	56,373	72,829	74,966	70,205	75,222	78,476	81,391	87,402	87,415	92,062	96,587
Gross profit	-	-	-	105,458	122,463	124,130	101,667	100,986	104,134	104,721	103,425	109,174	103,176	91,513
Gross margin (%)	-	-	-
Operating income	-	-	-	33,188	30,713	31,311	31,298	45,098	33,535	12,917	35,886	-3,090	38,541	46,880
Operating expenses	-	-	-	55,430	65,085	64,284	70,369	68,137	69,700	81,108	82,037	84,376	75,164	68,105
Income before tax	27,780	25,602	30,361	35,863	79,470	31,822	39,261	43,117	32,091	12,418	35,616	-5,799	29,874	47,481
Provision for income taxes	-	-	-	11,221	23,401	5,617	7,564	9,946	10,014	5,663	7,783	9,501	7,123	7,333
Net income	17,160	16,520	19,718	24,032	53,373	23,061	35,247	31,954	23,618	6,830	27,218	-14,948	26,642	36,256
Earnings per share	196.96	195.81	47.78	58.18	128.99	56.2	86.73	78.67	59.16	17.09	68.07	-38.6	72.59	103.98
Diluted EPS	196.76	195.51	41.33	54.41	123.79	60.7	62.36	68.76	68.46	54.33	43.53	-38.6	50.74	50.89
Dividend payout ratio (%)	-	-	-	-	-	-	-	-
Dividend per share	100	100	100	110	25	26	26	26	27	28	32	32	33	36

Raw aggregated data